Trypsin-encoding


Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
03 2019
Historique:
received: 06 06 2018
accepted: 16 11 2018
pubmed: 24 11 2018
medline: 12 5 2020
entrez: 24 11 2018
Statut: ppublish

Résumé

Asparaginase-associated pancreatitis is a life-threatening toxicity to childhood acute lymphoblastic leukemia treatment. To elucidate genetic predisposition and asparaginase-associated pancreatitis pathogenesis, ten trial groups contributed remission samples from patients aged 1.0-17.9 years treated for acute lymphoblastic leukemia between 2000 and 2016. Cases (n=244) were defined by the presence of at least two of the following criteria: (i) abdominal pain; (ii) levels of pancreatic enzymes ≥3 × upper normal limit; and (iii) imaging compatible with pancreatitis. Controls (n=1320) completed intended asparaginase therapy, with 78% receiving ≥8 injections of pegylated-asparaginase, without developing asparaginase-associated pancreatitis. rs62228256 on 20q13.2 showed the strongest association with the development of asparaginase-associated pancreatitis (odds ratio=3.75;

Identifiants

pubmed: 30467200
pii: haematol.2018.199356
doi: 10.3324/haematol.2018.199356
pmc: PMC6395330
doi:

Substances chimiques

Antineoplastic Agents 0
PRSS2 protein, human 103964-84-7
Polyethylene Glycols 3WJQ0SDW1A
pegaspargase 7D96IR0PPM
Trypsinogen 9002-08-8
PRSS1 protein, human EC 3.4.21.4
Trypsin EC 3.4.21.4
Asparaginase EC 3.5.1.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

556-563

Subventions

Organisme : Blood Cancer UK
ID : 10060
Pays : United Kingdom
Organisme : Blood Cancer UK
ID : 15014
Pays : United Kingdom
Organisme : Blood Cancer UK
ID : 12026
Pays : United Kingdom
Organisme : NIEHS NIH HHS
ID : R00 ES023504
Pays : United States
Organisme : NIEHS NIH HHS
ID : R21 ES025052
Pays : United States

Informations de copyright

Copyright© 2019 Ferrata Storti Foundation.

Références

Nucleic Acids Res. 2016 Jan 4;44(D1):D710-6
pubmed: 26687719
Nat Genet. 2012 Dec;44(12):1349-54
pubmed: 23143602
Trends Genet. 1997 Apr;13(4):163
pubmed: 9097728
Philos Trans R Soc Lond B Biol Sci. 2016 Aug 5;371(1700):
pubmed: 27377732
Nat Protoc. 2010 Sep;5(9):1564-73
pubmed: 21085122
Bioinformatics. 2018 Mar 1;34(5):887-889
pubmed: 28968746
Anal Biochem. 2004 Jan 15;324(2):309-11
pubmed: 14690699
Nat Rev Genet. 2009 May;10(5):318-29
pubmed: 19373277
Gut. 2018 Oct;67(10):1855-1863
pubmed: 28754779
Crit Rev Oncol Hematol. 1998 Aug;28(2):97-113
pubmed: 9768345
F1000Res. 2017 Apr 7;6:444
pubmed: 28413626
Lancet Oncol. 2017 Sep;18(9):1238-1248
pubmed: 28736188
Gut. 2015 Nov;64(11):1837-8
pubmed: 26246244
Nucleic Acids Res. 2001 Jan 1;29(1):308-11
pubmed: 11125122
Leukemia. 2017 Feb;31(2):325-332
pubmed: 27451978
Anal Biochem. 1999 Nov 1;275(1):84-92
pubmed: 10542112
Leukemia. 2010 Feb;24(2):320-34
pubmed: 20016537
Br J Haematol. 2012 Oct;159(1):18-27
pubmed: 22909259
J Clin Oncol. 2016 Jun 20;34(18):2133-40
pubmed: 27114598
Therap Adv Gastroenterol. 2017 Mar;10(3):323-336
pubmed: 28246549
Genome Res. 2012 Sep;22(9):1790-7
pubmed: 22955989
Nat Genet. 2013 Jun;45(6):580-5
pubmed: 23715323
Nature. 2018 Feb 15;554(7692):378-381
pubmed: 29414946
J Clin Oncol. 2005 Oct 1;23(28):7161-7
pubmed: 16192600
Nat Genet. 1996 Oct;14(2):141-5
pubmed: 8841182
Lancet Oncol. 2016 Jun;17(6):e231-e239
pubmed: 27299279
Gut. 2015 Aug;64(8):1345-6
pubmed: 26002935
Blood. 2001 Mar 1;97(5):1211-8
pubmed: 11222362
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Pancreas. 2016 Sep;45(8):1153-7
pubmed: 26784911
Lancet Oncol. 2017 Sep;18(9):1148-1149
pubmed: 28884687
Bioinformatics. 2010 Sep 15;26(18):2336-7
pubmed: 20634204
N Engl J Med. 1969 Nov 6;281(19):1028-34
pubmed: 4898857
Nat Rev Cancer. 2017 Nov;17(11):692-704
pubmed: 29026206
Pediatr Blood Cancer. 2010 Feb;54(2):199-205
pubmed: 19672973

Auteurs

Benjamin O Wolthers (BO)

Department of Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, Copenhagen, Denmark.

Thomas L Frandsen (TL)

Department of Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, Copenhagen, Denmark.

Chirag J Patel (CJ)

Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.

Rachid Abaji (R)

CHU Sainte-Justine Research Center and Department of Pharmacology, University of Montreal, QC, Canada.

Andishe Attarbaschi (A)

Department of Pediatric Hematology and Oncology, St Anna Children's Hospital and Department of Pediatric and Adolescent Medicine, Medical University of Vienna, Austria.

Shlomit Barzilai (S)

Pediatric Hematology and Oncology, Schneider Children's Medical Center of Israel, Petah-Tikva, Israel and Sackler Faculty of Medicine, Tel Aviv University, Israel.

Antonella Colombini (A)

Department of Pediatrics, Ospedale San Gerardo, University of Milano-Bicocca, Fondazione MBBM, Monza, Italy.

Gabriele Escherich (G)

University Medical Center Eppendorf, Clinic of Pediatric Hematology and Oncology, Hamburg, Germany.

Marie Grosjean (M)

Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark.

Maja Krajinovic (M)

CHU Sainte-Justine Research Center and Department of Pharmacology, University of Montreal, QC, Canada.
Department of Pediatrics, University of Montreal, QC, Canada.

Eric Larsen (E)

Maine Children's Cancer Program, Scarborough, ME, USA.

Der-Cherng Liang (DC)

Division of Pediatric Hematology-Oncology, Mackay Memorial Hospital, Taipei, Taiwan.

Anja Möricke (A)

Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Department of Pediatrics, Kiel, Germany.

Kirsten K Rasmussen (KK)

Department of Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, Copenhagen, Denmark.

Sujith Samarasinghe (S)

Great Ormond Street Hospital for Children, London, UK.

Lewis B Silverman (LB)

Department of Pediatric Oncology, Dana-Farber Cancer Institute and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA, USA.

Inge M van der Sluis (IM)

Dutch Childhood Oncology Group, The Hague and Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.

Martin Stanulla (M)

Department of Pediatric Hematology and Oncology, Hannover Medical School, Germany.

Morten Tulstrup (M)

Department of Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, Copenhagen, Denmark.

Rachita Yadav (R)

Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark.
Molecular Neurogenetics Unit, Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.

Wenjian Yang (W)

St. Jude Children's Research Hospital, Department of Pharmaceutical Sciences, Memphis, TN, USA.

Ester Zapotocka (E)

University Hospital Motol, Department of Pediatric Hematology/Oncology, Prague, Czech Republic.

Ramneek Gupta (R)

Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark.

Kjeld Schmiegelow (K)

Department of Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, Copenhagen, Denmark Kjeld.Schmiegelow@regionh.dk.
Institute of Clinical Medicine, University of Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH